|
Life sciences sector in India is implementing technologies like machine learning, artificial intelligence, cloud computing, robotics, blockchain augmented and virtual reality to accelerate drug discovery, enabling transparency and efficiency in supply chain, improve patient outcomes, and drive sustainable healthcare innovation.
As the National Technology Day is observed annually on May 11, this year’s theme is ‘Empowering Indian Youth for Global Leadership in Science & Innovation for Viksit Bharat'. The day according to lifesciences companies is a reminder of how innovation can drive systemic change, and this is nowhere more evident than in healthcare.
Enbasekar D, co-founder & CTO, MediBuddy, noted, “We are leading the way in using advanced technologies to unlock new possibilities in how care is accessed, delivered, and experienced across India. As India’s largest digital health company, we’ve learnt that healthcare is not one-size-fits-all.”
That’s why our innovations are rooted in inclusivity—from voice-enabled consultations to hybrid care models via e-clinics and MediBuddy on Wheels. We are not just expanding access but creating continuity across their entire journey, ensuring patients get timely follow-ups, personalised care plans, and actionable health insights based on real-time data, he added.
From AI-assisted diagnosis to smart prescription systems like Rxpert and fraud detection engines like SHERLOCK, our tech-first approach ensures precision, safety, and trust at scale. Technology also plays a critical role in operational efficiency. With our microservices-driven architecture and MB Provider Central, we enable smoother coordination across our vast partner network—from labs to hospitals to home care. As we look to the future, MediBuddy remains committed to solving India's healthcare challenges not with isolated solutions but with a unified vision: a connected, intelligent, and compassionate health system powered by innovation, said Enbasekar.
According to Hari Kiran Chereddi, managing director & CEO, HRV & NHG Pharma, "Technology today has become the silent designer of the pharma industry's shift from molecules to markets.”
In research, machine learning and artificial intelligence are advancing molecule discovery, predicting trial success, and risk-reducing development pipelines. On the factory floor, digital twin-led intelligent factories and predictive analytics are optimizing yields, reducing downtime, and ensuring real-time compliance. And in business, technology is enabling hyper-personalized interaction, translating data into insights and insights into action, noted Chereddi.
Technology is not a tool, instead it is a way of thinking. A way of thinking that adds velocity, precision, and democratization to the essence of pharma so that the innovation reaches the patients faster, safer, and smarter than before, pointed out Chereddi.
In a bid to unlock the new possibilities in healthcare, research, and innovation, the life sciences sector in India sees technology as the answer for efficiency and drive economies of scale.
|